Acute renal failure secondary to angiotensin II receptor blockade in a patient with bilateral renal artery stenosis

Pharmacotherapy

Volumn 23, Issue 9 I, 2003, Pages 1199-1204

  Wargo, Kurt A ^a   Chong, Kenneth ^a   Chan, Evelyn C Y ^b  

^a MEMORIAL HERMANN HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM CARBONATE; CREATININE; DEXTROPROPOXYPHENE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; FERROUS SULFATE; FUROSEMIDE; GABAPENTIN; HYDRALAZINE; IPRATROPIUM BROMIDE; LOSARTAN; PARACETAMOL; SALBUTAMOL; TRAMADOL; UREA;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DIABETES MELLITUS; HEART FAILURE; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PERIPHERAL VASCULAR DISEASE; UREA NITROGEN BLOOD LEVEL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CREATININE; DIABETES COMPLICATIONS; DIABETES MELLITUS; DRUG LABELING; EMERGENCY TREATMENT; FUROSEMIDE; HUMANS; HYPERTENSION; KIDNEY FAILURE, ACUTE; LOSARTAN; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RECEPTORS, ANGIOTENSIN; RENAL ARTERY OBSTRUCTION;

EID: 0141456663     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.10.1199.32761     Document Type: Article

References (21)

1. Mimran A, Ribstein J. Angiotensin receptor blockers: pharmacology and clinical significance. J Am Soc Nephrol 1999;10(suppl 12):S273-7.
2. Pisoni R, Faraone R, Ruggenenti P, Remuzzi G. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency. J Nephrol 2002;15:428-30.
3. Novick AC, Fergany A. Renovascular hypertension and ischemic nephropathy In: Walsh PC, Retik AB, Vaughan ED, et al, eds. Campbell's urology. St. Louis, MO: WB Saunders, 2002:235-8.
4. Chandrasekharan UM, Sanker S, Glynias MJ, Karnik SS, Husain A. Angiotensin II-forming activity in a reconstructed ancestral chymase. Science 1996;271:502-5.
5. Urata H, Boehm KD, Philip A, et al. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 1993;91:1269-81.
6. Nishimura H, Hoffmann S, Baltatu O, Sugimura K, Ganten D, Urata H. Angiotensin I converting enzyme and chymase in cardiovascular tissues. Kidney Int 1996;55:S18-23.
7. Liu YH, Yang XP, Sharov VG, et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997;99:1926-35.
8. Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial: the losartan heart failure survival study ELITE 11. Lancet 2000;355:1582-7.
9. Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001;345:1667-75.
10. Burnier M, Brunner HR. Angiotensin II receptor antagonists. Lancet 2000;355:637-45.
11. Mogensen CE, Neldam S, Tikkanen I, et al. Randomized controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ 2000;321:1440-4.
12. American Diabetes Association. Diabetic nephropathy. Diabetes Care 2003;26:S94-8.
13. Safian RD, Textor SC. Renal artery stenosis. N Engl J Med 2001;344:431-42.
14. Simon G. What is critical renal artery stenosis? Am J Hypertens 2000;13:1189-93.
15. Mimran A, Ribstein J, Du Cailar G. Converting enzyme inhibitors and renal function in essential and renovascular hypertension. Am J Hypertens 1991;4(1 pt 2):7S-14.
16. Ahmed A. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? J Am Geriatr Soc 2002;50:1297-300.
17. Mimran A, Ribstein J, DuCailar G. Comparison of the acute renal effects of losartan and captopril in atheromatous renovascular disease. Am J Hypertens 1998;11:47A.
18. Johansen TL, Kjaer A. Reversible renal impairment induced by treatment with the angiotensin 11 receptor antagonist candesartan in a patient with bilateral renal artery stenosis. BMC Nephrology 2001;2:1.
19. Missouris CG, Ward DE, Eastwood JB, MacGregor GA. Deterioration in renal function with enalapril but not losartan in a patient with renal artery stenosis in a solitary kidney Heart 1997;77:391-2.
20. Saine DR, Ahrens ER. Renal impairment associated with losartan. Ann Intern Med 1996;124:775.
21. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.